Leaflet: information for the user
Alprazolam Teva-ratiopharm 1 mg tablets EFG
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
|
1. What Alprazolam Teva-ratiopharm is and what it is used for
2. What you need to know before you start taking Alprazolam Teva-ratiopharm
3. How to take Alprazolam Teva-ratiopharm
4. Possible side effects
5. Storage of Alprazolam Teva-ratiopharm
6. Contents of the pack and additional information
Alprazolam belongs to a group of medicines called benzodiazepines (anxiolytic medicines).
Alprazolam Teva-ratiopharm is used in adults for the treatment of severe, debilitating, or anxiety-provoking symptoms of anxiety.
This medicine is only for short-term use.
Do not take Alprazolam Teva-ratiopharm
Warnings and precautions
Consult your doctor or pharmacist before starting to take Alprazolam Teva-ratiopharm
Taking Alprazolam Teva-ratiopharm with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Alprazolam may interact with other medications. Inform your doctor if you are taking any of the following medications:
There are some groups of medications that, due to their action in the body (inhibitors of cytochrome P450), may interact with Alprazolam Teva-ratiopharm and, in some cases, may increase the activity of alprazolam. Some of the medications that interact with alprazolam are:
Taking Alprazolam Teva-ratiopharm with food, drinks, and alcohol
During treatment, avoid alcoholic beverages. The effect of alcohol may potentiate sedation, and this may affect your alertness (see section "Driving and operating machines").
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Alprazolam Teva-ratiopharm is not recommended during pregnancy or breastfeeding, unless, in the doctor's opinion, the benefit outweighs the risk for the baby.
If, at the doctor's discretion, this medication is administered during a late stage of pregnancy or during delivery, certain effects may appear in the newborn, such as moderate respiratory depression, decreased body temperature (hypothermia), and decreased muscle tone (hypotonia). Newborns born to mothers who take benzodiazepines chronically during the last period of pregnancy may develop physical dependence, which may trigger a withdrawal syndrome in the postnatal period.
Special groups of patients
If your liver or kidneys do not function well, consult your doctor, who may advise you to use a lower dose of this medication.
If you have respiratory problems, inform your doctor.
Use in elderly patients (over 65 years)
Alprazolam may affect this group of patients more than young patients. If you belong to this group, your doctor may reduce the dose and check your response to treatment. Please follow your doctor's instructions carefully (see section "How to take Alprazolam Teva-ratiopharm").Benzodiazepines and related products should be used with caution in elderly patients due to the risk of sedation and/or muscle weakness that may cause falls, often with serious consequences in this population.
Use in children and adolescents (under 18 years)
Alprazolam is not recommended for children and adolescents under 18 years. Benzodiazepines should not be administered to children unless strictly necessary and prescribed by a doctor.
Driving and operating machines
Alprazolam Teva-ratiopharm may affect your ability to drive or operate machinery, as it may cause drowsiness, decrease your attention, or decrease your reaction time. These effects are more likely to occur at the beginning of treatment or when the dose is increased, do not drive or operate machinery if you experience any of these effects.
These effects may be potentiated if you consume alcohol at the same time.
Alprazolam Teva-ratiopharm contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Alprazolam Teva-ratiopharm contains amaranth colorant (E123)
It may cause allergic reactions.
Alprazolam Teva-ratiopharm contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Dosage:
The tablet or its part will be ingested without chewing, with the help of a little liquid. Your doctor will prescribe the alprazolam presentation most suitable for you, according to the dose you need.
The groove is only used to break the tablet if it is difficult for you to swallow it whole.
The usual doses are as follows:
In elderly patients, with chronic respiratory insufficiency, liver or kidney impairment, the recommended initial dose is 0.25 mg of alprazolam, 2 or 3 times a day, with a daily alprazolam intake of 0.5 mg to 0.75 mg in divided doses, which can be gradually increased as needed and well tolerated.
Each individual dose should not exceed the indicated limits, and the total daily dose should not either, unless your doctor indicates otherwise.
Duration and discontinuation of treatment:
The maximum duration of treatment should not exceed 2 – 4 weeks. Long-term treatment is not recommended. If your doctor considers that in your case it is necessary to prolong the treatment, they will do so for limited periods and will frequently monitor your situation.
You should never stop treatment abruptly. Your doctor will indicate the duration of treatment depending on the evolution of your disease and will explain how to gradually reduce the dose until you complete your treatment.
If you estimate that the action of alprazolam is too strong or too weak, inform your doctor or pharmacist.
If you take more Alprazolam Teva-ratiopharm than you should
If you have taken more alprazolam than you should, consult your doctor or pharmacist immediately or go to the nearest hospital with this leaflet.
Benzodiazepine overdose generally manifests by different degrees of central nervous system depression, ranging from drowsiness to coma. Symptoms include drowsiness (somnolence), speech disorders (dysarthria), coordination disturbances, confusion, lethargy (a state of deep and prolonged somnolence), muscle tone decrease (hypotonia), blood pressure drop, respiratory depression, rarely coma, and very rarely death. Serious sequelae are rare, unless alprazolam is taken with other medications or alcohol.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Alprazolam Teva-ratiopharm
Do not take a double dose to compensate for the missed doses.If the missed dose is recent, take your dose immediately and if not, wait for the next dose without taking a double dose to compensate.
If you interrupt treatment with Alprazolam Teva-ratiopharm
Treatment with alprazolam can cause dependence, so when stopping alprazolam administration abruptly, withdrawal symptoms may appear.
The withdrawal symptoms that may occur are: headache, muscle pain, anxiety, tension, restlessness, confusion, irritability, general feeling of disgust (dysphoria), insomnia, intolerance to light, sounds, and physical contact, paresthesias and cramps in the limbs and abdomen, vomiting, sweating, tremors, depersonalization, hallucinations, and seizures. If this occurs, you should consult your doctor immediately.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The side effects that may occur during treatment with Alprazolam Teva-ratiopharm predominantly occur at the beginning of treatment and generally disappear with continued administration or after a dose reduction.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Frequency not known (cannot be estimated from available data):
With the use of benzodiazepines, the following may occur:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https//www.notificaram.es.By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofAlprazolam Teva-ratiopharm 1 mg tablets
The active ingredient is alprazolam. Each tablet contains 1 mg of alprazolam.
The other components are: lactose monohydrate, microcrystalline cellulose, cornstarch, talc, carboxymethylcellulose sodium type A (from potato), magnesium stearate, patent blue V (E131) dye, and amaranth (E123) dye.
Appearance of the product and contents of the packaging
Blue scored tablets.
The score is only for fracturing and facilitating swallowing, but not for dividing into equal doses.
Packaging with 30 tablets.
Holder of the marketing authorization and responsible manufacturer
Holder
Teva Pharma, S.L.U.
C/Anabel Segura 11, Edificio Albatros B, 1st floor,
Alcobendas, 28108 Madrid (Spain)
Responsible manufacturer
LACER, S.A.
C/ Boters, 5 – Parc Tecnológic del Vallés
08290 Cerdanyola del Vallés (Barcelona, Spain)
Date of the last review of this leaflet:April 2022
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medication by scanning the QR code included in the carton with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/63876/P_63876.html
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.